1. Is ¹⁸FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

   • David Groheux
   • Elif Hindié

   Editorial Commentary 01 June 2016 Pages: 1571 - 1573

2. Association between partial-volume corrected SUV_max and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer

   • Su Hyun Lee
   • Seunggyun Ha
   • Gi Jeong Cheon

   Original Article 21 May 2016 Pages: 1574 - 1584

   

3. Direct comparison of ⁶⁸Ga-DOTA-TOC and ¹⁸F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

   • Bernhard Nilica
   • Dietmar Waitz
   • Margarida Rodrigues

   Original Article Open access 27 February 2016 Pages: 1585 - 1592

   

4. Role of ⁶⁸Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study

   • Vikas Prasad
   • Aurora Sainz-Esteban
   • Oliver Blankenstein

   Original Article 29 February 2016 Pages: 1593 - 1600

   

5. ¹⁸F-FACBC (anti1-amino-3-¹⁸F-fluorocyclobutane-1-carboxylic acid) versus ¹¹C-choline PET/CT in prostate cancer relapse: results of a prospective trial

   • Cristina Nanni
   • Lucia Zanoni
   • Stefano Fanti

   Original Article 10 March 2016 Pages: 1601 - 1610

   

6. Radiation dosimetry of ⁶⁸Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing

   • Ali Afshar-Oromieh
   • Henrik Hetzheim
   • Uwe Haberkorn

   Original Article 03 June 2016 Pages: 1611 - 1620

   

7. RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study

   • Shih-Hsin Chen
   • Hung-Ming Wang
   • Tzu-Chen Yen

   Original Article 27 February 2016 Pages: 1621 - 1629

   

8. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei

   • Julien Dubreuil
   • Francesco Giammarile
   • Andrea Skanjeti

   Original Article 24 February 2016 Pages: 1630 - 1637

   

9. Prognostic value of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study

   • Seung Hyup Hyun
   • Jae Seon Eo
   • Mijin Yun

   Original Article 02 March 2016 Pages: 1638 - 1645

   

10. ¹⁸F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease

    • Verena Ruhlmann
    • Thorsten Dirk Poeppel
    • Lale Umutlu

    Original Article 11 March 2016 Pages: 1646 - 1652

    

11. [¹¹C]TASP457, a novel PET ligand for histamine H₃ receptors in human brain

    • Yasuyuki Kimura
    • Chie Seki
    • Tetsuya Suhara

    Original Article 23 February 2016 Pages: 1653 - 1663

    

12. Ability of ¹⁸F-DOPA PET/CT and fused ¹⁸F-DOPA PET/MRI to assess striatal involvement in paediatric glioma

    • Giovanni Morana
    • Matteo Puntoni
    • Arnoldo Piccardo

    Original Article 25 February 2016 Pages: 1664 - 1672

    

13. Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers

    • Philip J. O’Halloran
    • Thomas Viel
    • Annette T. Byrne

    Original Article 15 March 2016 Pages: 1673 - 1683

    

14. Tau PET and tauopathies

    • Karl Herholz

    Editorial Commentary 10 May 2016 Pages: 1684 - 1685

15. Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm

    • Konstantinos Chiotis
    • Laure Saint-Aubert
    • Agneta Nordberg

    Original Article Open access 21 March 2016 Pages: 1686 - 1699

    

16. Early [¹⁸F]florbetaben and [¹¹C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease

    • Solveig Tiepolt
    • Swen Hesse
    • Henryk Barthel

    Original Article 30 March 2016 Pages: 1700 - 1709

    

17. In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [¹⁸F]GE-180 and effect of docosahexaenoic acid

    • J. L. Tremoleda
    • O. Thau-Zuchman
    • A. T. Michael-Titus

    Original Article Open access 07 May 2016 Pages: 1710 - 1722

    

18. The EANM practice guidelines for bone scintigraphy

    • T. Van den Wyngaert
    • K. Strobel
    • On behalf of the EANM Bone & Joint Committee and the Oncology Committee.

    Guidelines Open access 04 June 2016 Pages: 1723 - 1738

    

19. ¹⁸F-FDG PET/CT in patients with idiopathic retroperitoneal and mediastinal fibrosis

    • R. Fernández-López
    • J. A. Lojo
    • I. Borrego-Dorado

    Image of the Month 01 March 2016 Pages: 1739 - 1740

    

20. Severe early basal ganglia hypometabolism in neurodegeneration with brain iron accumulation

    • Ismini C. Mainta
    • C. Tabouret-Viaud
    • V. Garibotto

    Image of the Month 19 March 2016 Pages: 1741 - 1742

    

21. William T. O’Brien Sr. (Ed.), Top 3 Differentials in Neuroradiology: A Case Review. Thieme Medical Publishers, Inc., 2015. ISBN 978-1- 60406-723-1

    • Davide D’Arienzo
    • Luigi Mansi

    Book Review 19 March 2016 Pages: 1743 - 1743

22. Andreas Engert and Anas Younes (Eds), Hodgkin Lymphoma: A Comprehensive Overview

    • Flavia Galante
    • Luigi Mansi

    Book Review 23 March 2016 Pages: 1744 - 1745

23. Andrew M. Evens and Kristie A. Blum (Eds), Non-Hodgkin Lymphoma. Pathology, Imaging, and Current Therapy

    • Sara Pellegrino
    • Luigi Mansi

    Book Review 23 March 2016 Pages: 1746 - 1746

24. Erratum to: Dual-phase amyloid PET: hitting two birds with one stone

    • Valentina Garibotto
    • Silvia Morbelli
    • Marco Pagani

    Erratum 24 May 2016 Pages: 1747 - 1747